Are there any differences between adult-onset rheumatoid arthritis patients and late-onset rheumatoid arthritis patients in terms of use of biological drugs and drug retention rate? Results from the Turkbio registry

Yazici, A.Cefle, A.Can, G.Senel, S.Koca, S. S.Inanc, N.Goker, B.Yilmaz, S.Akar, S.Soysal, O.Ozturk, M. A.Sari, I.Direskeneli, H.Onen, F.2024-07-032024-07-032020-06-010003-4967https://doi.org/10.1136/annrheumdis-2020-eular.1625https://hdl.handle.net/11452/42761Bu çalışma, 03 Haziran 2010 tarihleri arasında düzenlenen Annual European Congress of Rheumatology (EULAR)’da bildiri olarak sunulmuştur.eninfo:eu-repo/semantics/closedAccessScience & technologyLife sciences & biomedicineRheumatologyRheumatologyAre there any differences between adult-onset rheumatoid arthritis patients and late-onset rheumatoid arthritis patients in terms of use of biological drugs and drug retention rate? Results from the Turkbio registryMeeting Abstract00055590500320299699679Supplement 110.1136/annrheumdis-2020-eular.1625